BALPHARMA
Bal Pharma Ltd.
Pharmaceuticals & Drugs
Setup readiness
Early Trend
- Pivot Levels
- ₹94.1-99.3
- Support Level
- ₹90.8
- Resistance
- ₹118.6
- Risk Distance
- 8.6% to stop
Reference levels for educational study only. Not a recommendation to buy or sell.
Swing Edge Intelligence
Structured setup analysis · research only
Setup status · Mixed technical setup
Some technical elements are present, but overall momentum and structure remain mixed.
Bullish factors
- MACD below zero — weak trend (−2).
- Moderate distance from 52w high (-20% below).
- Price remains distant from the pivot zone.
- 1 prior pivot rejection in last 60d (-8 pts).
- ATR 5.1%/day — healthy volatility (+4).
- ATR shrinking 3 consecutive weeks — coil forming.
- BB squeeze — energy building.
- Pivot quality 42/100 — sloppy pivot zone.
Risk factors
- Low average daily value (₹0.2 Cr/day)
- Stop distance is wide (9%)
- 9 distribution days observed recently
Overall view
The setup is still developing with mixed momentum and trend alignment.
Setup research
BALPHARMA — trend, RS & risk snapshot (not a trade recommendation)
Signal · context · invalidation · risk · skip reasons — research only
Positives
Price is 16% below the pivot
- Stage 2 uptrend structure detected
Context & regime
- Market regime Mixed / range-bound
- Trend stage Stage 2 — tradable
- Sector Mid-pack (#23/46)
- Relative strength Lagging (RS 54)
- Trend strength Weak (ADX 19)
Negatives
This idea is wrong below ₹90.8 (-9.0% away)
Base / stop support breaks — the swing thesis is wrong below here
- Stop / base low₹90.8
- Pivot — failure re-entry below₹98.8
Risk distance
Risk ≈ ₹8.54/share from entry ₹99.3.
Stop is wide (9%) for a swing — sizing will be small
Reasons to skip 4
Disqualifiers that apply even if the score looks good.
- Low average daily value (₹0.2 Cr/day)
- Stop distance is wide (9%)
- 9 distribution days observed recently
- High failure risk score (78/100)
Setup metrics Latest scan
BALPHARMA Technical Analysis & Swing Setup
Grouped structure, momentum and risk from the latest research scan.
Volume Profile bearish
- POC
- ₹88.25
- VAH
- ₹94.53
- VAL
- ₹81.98
- Vol above POC
- 44.9%
Institutional Activity · Distribution
- Avg cost basis
- ₹83.55
- Acc zone
- ₹66.3–89.5
- Accumulation sessions
- 6
- CMF
- -0.36
Structure
Momentum
Risk
More scanner fields
BALPHARMA Support & Resistance Levels
Research chart
Daily price action with pivot, support, and resistance levels from our latest scan, plus relative strength vs Nifty.
Pivot levels, support and resistance are drawn on the price chart. · Research only.
Sector RS rank · latest scan
Loading peer comparison…
Seasonality — monthly returns
How this stock moved month by month over the last ~2 years.
A rough tendency, not a reliable pattern. Research only, not advice.
AI insights
AI Insights
Generated with AIThese insights are AI-generated to support your research process and should not be treated as investment advice or a recommendation to buy or sell securities.
Sign in to unlock AI Insights
Personalised swing trade analysis powered by Gemini AI
Pattern context 52w · setup · flow
52-week range
—Stage-2 ideal band · Early recovery
Pattern highlights
Pattern signals from the latest scan
Smart money flow
Last 60 sessions · accumulation vs distribution
Setup intelligence Overhead · VCP · radar · risk
Overhead supply
Resistance ceiling above current price
Chase / failure risk
Honest read on exhaustion & extended moves
Base / VCP coil
Depth, contractions & pivot distance
Setup quality radar
Shape of the setup in one view
Peer comparison Sector peers
Sector Peer Comparison
Loading sector peers…
BALPHARMA FAQ Common swing-trading questions
Frequently asked questions about BALPHARMA
What are the screener observations for BALPHARMA?
On Swing Edge's swing-setup framework, Bal Pharma Ltd. (BALPHARMA) currently grades D — low-quality — likely skip. Price is 16% below the pivot. Flagged yesterday. This is educational research, not investment advice.
What are BALPHARMA's support and resistance levels?
For BALPHARMA, near-term support sits around ₹90.8 (the base/stop zone); overhead resistance is around ₹98.8 (the breakout pivot); the next resistance above is ₹118.6. This is educational research, not investment advice.
What is the breakout / pivot level for BALPHARMA?
The breakout pivot for BALPHARMA is around ₹98.8. Price is about 15.8% below the pivot and still building toward it. A breakout is typically confirmed on a close above the pivot with above-average volume. This is educational research, not investment advice.
Is BALPHARMA above its 50-day and 200-day moving averages?
Yes — BALPHARMA is in a confirmed Stage 2 uptrend, trading above its rising 50- and 200-day moving averages, the zone where swing setups tend to work best. This is educational research, not investment advice.
How strong is BALPHARMA versus the market (RS rank)?
BALPHARMA has a relative strength (RS) rank of 54 out of 100 versus the NSE universe, making it lagging the broader market on relative strength. Trend strength (ADX) reads 19, indicating a weak/choppy trend. This is educational research, not investment advice.
Answers are generated from Swing Edge's latest scan data and are for research only — not investment advice.
Prices and day-change figures use the last daily close from scan data dated 2026-06-28 — not live intraday NSE quotes.